Although one study reported that FOXA1 expression was correlated with the luminal A subtype and a favorable outcome [38], others depicted a complicated picture of FOXA1 as a participant in multiple signaling pathways in breast cancer, which are both oncogenic and tumor suppressive [33]. The gene discussed is FOXA1; the disease is neoplasm.